Pharmafile Logo
Pharmafocus logo
Advanced Search

Adaptimmune

Showing 9 posts of 9 posts found.

Adaptimmune receives US FDA Accelerated Approval for engineered cell therapy for a solid tumour

August 2, 2024
Medical Communications Adaptimmune, Oncology, accelerated approval, engineered cell therapy, oncology, synovial sarcoma

Adaptimmune Therapeutics has announced today that the US Food and Drug Administration (FDA) has given accelerated approval for TECELRA (afamitresgene …

News
adaptimmune_lab_scientists_growing_research_cells_jpg-web

Bad news for Adaptimmune as partial clinical hold placed on T-cell oncology trial

August 4, 2016
Research and Development Adaptimmune, T cell, oncology, t-cell

Adaptimmune Therapeutics has received notice from the US Food and Drug Administration (FDA) that a partial clinical hold has been …

News
Adaptimmune

GSK and Adaptimmune expand R&D collaboration

February 3, 2016
Research and Development Adaptimmune, GSK, T-cell therapy, immunotherapy, liposarcoma, rare cancer, sarcoma

Adaptimmune Therapeutics and GlaxoSmithKline have expanded the terms of their strategic collaboration agreement, to run clinical trials of Adaptimmune’s potential …

News
rafael_amado

Adaptimmune makes executive hires from GSK

March 5, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, Adrian Rawcliffe, Rafael Amado

UK and US clinical-stage biotech firm Adaptimmune has increased its senior team with the appointment of Dr Rafael Amado as …

Appointment
david_mott_adaptimmune

Adaptimmune board changes amid funding boost

September 29, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, Ali Behbahani, Elliott Sigal, Peter Thompson, david mott

Oxford-based biotech firm Adaptimmune has secured some significant financial support whilst also making changes to its board. David Mott (pictured), …

Appointment

GSK signs Adaptimmune deal

June 3, 2014
Manufacturing and Production, Research and Development, Sales and Marketing AZ, Adaptimmune, BMS, Cancer, GSK, oncology

GlaxoSmithKline has signed a deal to develop and commercialise biotech firm Adaptimmune’s lead clinical cancer programme with T-cell receptors (TCRs), …

News
screen_shot_2014-03-27_at_07

Immunocore chief executive cements role at Adaptimmune

March 27, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, immunocore, noble

Biotech firm Adaptimmune has confirmed the full-time appointment of James Noble as its chief executive. Noble has been chief executive …

Appointment

Adaptimmune wins fund payout

March 26, 2014
Research and Development, Sales and Marketing Adaptimmune, Cancer, T cell, biomedical, noble, sme

Biotech firm Adaptimmune has been awarded £2.1 million from the UK government’s Biomedical Catalyst Fund, which was set up to …

News
Helen Tayton-Martin

Working Life: Adaptimmune’s Helen Tayton-Martin

October 31, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, Working Life

Helen Tayton-Martin who is an executive director at Adaptimmune, talks to Pharmafocus about her role and working in cell therapy. …

Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025